13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001524362
Total reported value
—
$135.4M
10 檔
82.9%
During the Q2 2025 filing period, Indaba Capital Management, L.P. (CIK: 0001524362) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $135.4M across 10 reported positions.
In Q2 2025, Indaba Capital Management, L.P. adopted a defensive or profit-taking posture, trimming 0 positions and completely liquidating 2 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BAND 0.5 04-01-28Bond | Bandwidth Inc | Bond | 24.95% | — | — | |
| 2 | INN 1.5 02-15-26Bond | Summit Hotel Properties | Bond | 20.79% | — | — | |
| 3 | ONTF | On24 Inc | Stock-Other | 17.01% | — | — | |
| 4 | IRWD 1.5 06-15-26Bond | Ironwood Pharmaceuticals | Bond | 10.65% | — | — | |
| 5 | TVTX 2.5 09-15-25Bond | Travere Therapeutics Inc | Bond | 9.49% | — | — | |
| 6 | BLKB | Blackbaud Inc | Stock-Other | 9.15% | — | — | |
| 7 | BATRK | Atlanta Braves Holdings In-c | Stock-Other | 3.24% | — | — | |
| 8 | ESPR | Esperion Therapeutics Inc | Stock-Other | 2.18% | — | — | |
| 9 | EMBC | Embecta CORP | Stock-Healthcare | 1.59% | — | — | |
| 10 | ADV | Advantage Solutions Inc. | Stock-Other | 0.96% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BAND 0.5 04-01-28Bond | Bandwidth Inc | +5.5% | — | Unchanged |
| 2 | INN 1.5 02-15-26Bond | Summit Hotel Properties | +4.1% | — | Unchanged |
| 3 | ONTF | On24 Inc | +3.8% | — | Unchanged |
| 4 | BLKB | Blackbaud Inc | +2% | — | Unchanged |
| 5 | TVTX 2.5 09-15-25Bond | Travere Therapeutics Inc | +1.8% | — | Unchanged |
| 6 | IRWD 1.5 06-15-26Bond | Ironwood Pharmaceuticals | +1.6% | — | Unchanged |
| 7 | BATRK | Atlanta Braves Holdings In-c | +1% | — | Unchanged |
| 8 | ADV | Advantage Solutions Inc. | +0.1% | — | Unchanged |
| 9 | EMBC | Embecta CORP | -0.1% | — | Unchanged |
| 10 | ESPR | Esperion Therapeutics Inc | -0.4% | — | Unchanged |
| 11 | HP5A | Equity Commonwealth | -8.1% | EXIT | Sold out |
| 12 | AXDX 5 12-15-26Bond | Accelerate Diagnostics | -11.1% | EXIT | Sold out |
According to official SEC Form 13F filings, Indaba Capital Management, L.P. reported a total U.S. public equity portfolio value of $135.4M across 10 disclosed positions in Q2 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including BAND 0.5 04-01-28, INN 1.5 02-15-26, ONTF) accounted for 82.9% of total reported equity market value during Q2 2025.
Top Position Liquidated / Trimmed
AXDX 5 12-15-26
前期市值: $18.5M
During Q2 2025, Indaba Capital Management, L.P.'s top holdings by market value included BAND 0.5 04-01-28 (24.9%)、INN 1.5 02-15-26 (20.8%)、ONTF (17.0%). The largest single position, BAND 0.5 04-01-28, represented 24.9% of total portfolio value.
In Q2 2025, Indaba Capital Management, L.P. made 2 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 2 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.